Scalp stratum corneum histamine levels: Novel sampling method reveals association with itch resolution in dandruff/seborrhoeic dermatitis treatment

Acta Dermato-Venereologica

Volumn 91, Issue 4, 2011, Pages 404-408

  Kerr, Kathy ^a   Schwartz, James R ^a   Filloon, Thomas ^a   Fieno, Angela ^a   Wehmeyer, Ken ^a   Szepietowski, Jacek C ^b,c   Mills, Kevin J ^a  

^a PROCTER AND GAMBLE COMPANY   (United States)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Dandruff; Histamine; Pruritus; Seborrhoeic dermatitis; Stratum corneum: scalp

Indexed keywords

HISTAMINE; PYRITHIONE ZINC;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DANDRUFF; DISEASE SEVERITY; FEMALE; HISTAMINE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; SCALP PRURITUS; SEBORRHEIC DERMATITIS; STRATUM CORNEUM; VISUAL ANALOG SCALE;

ADMINISTRATION, TOPICAL; ADULT; ANALYSIS OF VARIANCE; ANTIPRURITICS; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DERMATITIS, SEBORRHEIC; DOUBLE-BLIND METHOD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HAIR PREPARATIONS; HISTAMINE; HUMANS; KERATOLYTIC AGENTS; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PRURITUS; PYRIDINES; QUESTIONNAIRES; SCALP; SCALP DERMATOSES; SKIN; SPECIMEN HANDLING; TANDEM MASS SPECTROMETRY; TIME FACTORS; TREATMENT OUTCOME;

EID: 79958779438     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-1073     Document Type: Article

References (25)

1. Warner RR, Schwartz JR, Boissy Y, Dawson JR. TL. Dandruff has an altered stratum corneum ultrastructure that is improved with zinc pyrithione shampoo. J Am Acad Der-matol 2001; 45: 897-903.
2. Ashbee HR, Evans EGV. Immunology of diseases associated with Malassezia species. Clin Microbiol rev 2002; 15: 21-57.
3. Chen SC, yeung J, Chren M. Scalpdex. A quality-of-life instrument for scalp dermatitis. Arch Dermatol 2002; 138: 803-807.
4. Akdis CA, Jutel M, Akdis M. regulatory effects of histamine and histamine receptor expression in human allergic and immune responses. Chem Immunol Allergy 2008; 94: 67-82.
5. Zampelli E, Tiligada E. The role of histamine H4 receptor in immune and infammatory disorders. Br J Pharmacol 2009; 157: 24-33.
6. Twycross R, Greaves MW, Handwerker H, Jones EA, Libretto SE, Szepietowski JC, et al. Itch: scratching more than the surface. Q J Med 2003; 96: 7-26.
7. Herman SM, Vender RB. Antihistamines in the treatment of dermatitis. J Cutan Med Surg 2003; 7: 467-473.
8. reich A, Szepietowski JC. Mediators of pruritis in psoriasis. Mediators Infamm 2007; 47: 861-863.
9. Ashida Y, Denda M. Dry environment increases mast cell number and histamine content in dermis in hairless mice. Br J Dermatol 2003; 149: 240-247.
10. Danarti R, Waskito F, Indrastuti N. Onset and duration of action of topical antihistamine: a study of histamine skin test response. Intl J Dermatol 2008; 106: 785-789.
11. Giustizieri ML, Albanesi C, Fluhr J, Gisondi P, Norgauer J, Girolomoni G. H1 histamine receptor mediates infam-matory responses in human keratinocytes. J Allergy Clin Immunol 2004; 114: 1176-1182.
12. Malaviya R, Morrison AR, Pentland AP. Histamine in human epidermal cells is induced by ultraviolet light injury. J Invest Dermatol 1996; 106: 785-789.
13. Harding CR, Moore AE, Rogers JS, Meldrum H, Scott AE, McGlone FP. Dandruff: a condition characterized by decreased levels of intercellular lipids in scalp stratum corneum and impaired barrier function. Arch Dermatol res 2002; 294: 221-230.
14. Kerr K, Darcy T, Henry J, Mizoguchi H, Schwartz JR, Morrall S, et al. A description of epidermal changes associated with symptomatic resolution of dandruff: biomarkers of scalp health. Int J Dermatol 2011; 50: 102-113.
15. Schwartz JR. Product pharmacology and medical actives in achieving therapeutic benefts. J Invest Dermatol Symp Proc 2005; 10: 198-200.
16. Billhimer WL, Bryant PB, Murray KP, Coffndaffer TW, Rains GY, Amon RB, et al. Results of clinical trial comparing 1% pyrithione zinc and 2% ketoconazole shampoos. Cosm Derm 1996; 9: 34-39.
17. Behrendt H, Ring J. Histamine, antihistamines and atopic eczema. Clin Exp Allergy 1990; 20 Suppl 4: 25-30.
18. Petersen L, Hansen U, Kristensen JK, Nielsen H, Skov PS, Nielsen HJ. Studies on mast cells and histamine release in psoriasis: the effect of ranitidine. Acta Derm Venereol 1998; 78: 190-193.
19. Krogstad AL, Lonnroth P, Goran L, Wallin BG. Increased interstitial histamine concentration in the psoriatic plaque. J Invest Dermatol 1997; 109: 632-635.
20. Johnson BA, Nunley JR. Treatment of seborrheic dermatitis. Amer Fam Phys 2000; 61: 2703-2710.
21. Goldstein SM, Kaempfer CE, Proud D, Schwartz LB, Irani AM, Wintroub BU. Detection and partial characterization of a human mast cell carboxypeptidase. J Immunol 1987; 139: 2724-2729.
22. Gallia SJ, Maurer M, Lantz CS. Mast cells as sentinels of innate immunity. Curr Opin Immunol 1999; 11: 53-59.
23. Stander S, Steinhoff M, Schmelz M, Weisshaar E, Metze D, Luger T. Neurophysiology of pruritus. Arch Dermatol 2003; 139: 1463-1470.
24. Yosipovitch G, Greaves MW, Schmelz M. Itch. Lancet 2003; 361: 690-694.
25. Kwon YS, Oh SH, Wu WH, Bae BG, Lee HJ, Lee MG, et al. CC chemokines as potential immunologic markers correlated with clinical improvement of atopic dermatitis patients by immunotherapy. Exp Dermatol 2009; 19: 246-251.